OTCMKTS:MKKGY Merck KGaA (MKKGY) Stock Price, News & Analysis $32.78 -0.29 (-0.88%) As of 03:50 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsNews and TrendsShort Interest About Merck KGaA Stock (OTCMKTS:MKKGY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Merck KGaA alerts:Sign Up Key Stats Today's Range$32.76▼$33.1850-Day Range$29.85▼$34.0852-Week Range$23.73▼$34.19Volume812,801 shsAverage Volume57,091 shsMarket Capitalization$21.18 billionP/E Ratio23.81Dividend Yield1.07%Price TargetN/AConsensus RatingHold Company Overview Merck KGaA is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co. The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility. Life Science supplies laboratory products, research tools and services, as well as materials and technologies used in pharmaceutical manufacturing. Through its Electronics division, Merck provides specialty materials and solutions for the semiconductor and display industries. The company serves customers internationally, with operations and markets spanning numerous regions around the world.AI Generated. May Contain Errors. Read More Merck KGaA Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks55th Percentile Overall ScoreMKKGY MarketRank™: 2.743110757815 of 5 starsMerck KGaA scored higher than 55% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingMerck KGaA has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 6 hold ratings, and no sell ratings.Amount of Analyst CoverageMerck KGaA has only been the subject of 2 research reports in the past 90 days.Read more about Merck KGaA's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth5.76% Earnings GrowthEarnings for Merck KGaA are expected to grow by 5.76% in the coming year, from $1.91 to $2.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Merck KGaA is 23.93, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.15.Price to Earnings Ratio vs. SectorThe P/E ratio of Merck KGaA is 23.93, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.34.Price to Earnings Growth RatioMerck KGaA has a PEG Ratio of 2.65. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMerck KGaA has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.01% of the float of Merck KGaA has been sold short.Short Interest Ratio / Days to CoverMerck KGaA has a short interest ratio ("days to cover") of 0.44, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Merck KGaA has recently decreased by 68.53%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldMerck KGaA pays a meaningful dividend of 1.06%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMerck KGaA does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Merck KGaA is 25.55%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Merck KGaA will have a dividend payout ratio of 17.33% next year. This indicates that Merck KGaA will be able to sustain or increase its dividend.Read more about Merck KGaA's dividend. News and Social Media2.0 / 5News Sentiment0.19 News SentimentMerck KGaA has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Merck KGaA this week, compared to 1 article on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Merck KGaA insiders have not sold or bought any company stock.Percentage Held by Institutions0.10% of the stock of Merck KGaA is held by institutions.Read more about Merck KGaA's insider trading history. Receive MKKGY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MKKGY Stock News HeadlinesMerck KGaA (MKKGY) - What Are Analysts Thinking About This Stock?November 16 at 2:04 AM | americanbankingnews.comMerck KGaA puts its shareholders' patience to the testNovember 12, 2026 | marketscreener.comMWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.November 16 at 1:00 AM | Porter & Company (Ad)Merck KGaA (MKKGY) lags Q3 earnings estimatesNovember 12, 2026 | msn.comMerck KGaA raises 2026 outlook as Bio-Techne deal nears completionNovember 12, 2026 | seekingalpha.comMerck KGaA Lifts Outlook Again on Life Science StrengthNovember 12, 2026 | bloomberg.comRBC Upbeat on Lonza's CDMO Deal with Merck KGaA; Forecasts UpdatedNovember 5, 2026 | marketscreener.comMMerck KGaA (MKKGY) Projected to Release Quarterly Earnings on ThursdayNovember 5, 2026 | americanbankingnews.comSee More Headlines MKKGY Stock Analysis - Frequently Asked Questions How have MKKGY shares performed this year? Merck KGaA's stock was trading at $28.68 on January 1st, 2026. Since then, MKKGY stock has increased by 14.3% and is now trading at $32.78. How were Merck KGaA's earnings last quarter? Merck KGaA (OTCMKTS:MKKGY) posted its earnings results on Wednesday, May, 13th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.45 by $0.14. The firm had revenue of $6.03 billion for the quarter, compared to analysts' expectations of $5.93 billion. Merck KGaA had a trailing twelve-month return on equity of 6.53% and a net margin of 8.95%. How do I buy shares of Merck KGaA? Shares of MKKGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:MKKGY Previous SymbolOTCMKTS:MKKGY CIKN/A Webwww.merckgroup.com Phone496151720Fax49-61-5172-2000Employees62,461Year Founded1668Profitability EPS (Trailing Twelve Months)$1.37 Trailing P/E Ratio23.93 Forward P/E Ratio16.23 P/E Growth2.65Net Income$2.95 billion Net Margins8.95% Pretax Margin14.42% Return on Equity6.53% Return on Assets3.68% Debt Debt-to-Equity Ratio0.37 Current Ratio1.69 Quick Ratio1.09 Sales & Book Value Annual Sales$23.87 billion Price / Sales0.89 Cash Flow$8.51 per share Price / Cash Flow3.85 Book Value$50.18 per share Price / Book0.65Miscellaneous Outstanding Shares646,210,000Free FloatN/AMarket Cap$21.18 billion OptionableNot Optionable Beta0.92 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:MKKGY) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.